Antimalarial drug | Treatment outcome | Sentinel site | Total | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
WRH | NWMH | YMH | SMH | BMH | BGH | HMH | TAGH | LEKMH | EWP | |||
AS–AQ | n = 51 | n = 55 | n = 0 | n = 54 | n = 63 | n = 62 | n = 61 | n = 61 | n = 23 | n = 62 | N = 492 | |
ETF | 0 | 1 | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |
LCF | 0 | 0 | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
LPF | 0 | 0 | – | 0 | 1 | 1 | 0 | 0 | 0 | 4 | 6 | |
ACPR | 45 | 54 | – | 51 | 62 | 58 | 58 | 60 | 20 | 58 | 466 | |
LFU | 5 | 0 | – | 3 | 0 | 3 | 3 | 1 | 3 | 0 | 18 | |
WTH | 1 | 0 | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Antimalarial drug | Treatment outcome | Sentinel site | Total | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
WRH | NWMH | YMH | SMH | BMH | BGH | HMH | TAGH | LEKMH | EWP | |||
AL | n = 0 | n = 58 | n = 60 | n = 43 | n = 63 | n = 63 | n = 60 | n = 58 | n = 0 | n = 67 | N = 472 | |
ETF | – | 0 | 0 | 1 | 0 | 0 | 0 | 2 | – | 0 | 3 | |
LCF | – | 0 | 0 | 0 | 1 | 1 | 0 | 0 | – | 0 | 2 | |
LPF | – | 5 | 3 | 3 | 3 | 1 | 0 | 12 | – | 9 | 36 | |
ACPR | – | 53 | 54 | 39 | 59 | 57 | 47 | 42 | – | 54 | 405 | |
LFU | – | 0 | 0 | 0 | 0 | 2 | 13 | 2 | – | 1 | 18 | |
WTH | – | 0 | 3 | 0 | 0 | 2 | 0 | 0 | – | 3 | 8 |